These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 4350186

  • 21. A new common marker for premalignant and malignant hepatocytes induced in the rat by chemical carcinogens.
    Okita K, Kligman LH, Farber E.
    J Natl Cancer Inst; 1975 Jan; 54(1):199-202. PubMed ID: 163316
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of rat lymph node cell cytotoxicity by hepatoma-associated embryonic antigen.
    Rees RC, Price MR, Baldwin RW, Shah LP.
    Nature; 1974 Dec 20; 252(5485):751-3. PubMed ID: 4373661
    [No Abstract] [Full Text] [Related]

  • 23. Hepatocellular localization of fetal antigens during induction of rat liver tumors by 3'-methyl-4-dimethylaminoazobenzene.
    Cauchi MN, Halley JB, Irving MG, Williams JF.
    Cancer Res; 1974 Aug 20; 34(8):1808-12. PubMed ID: 4367121
    [No Abstract] [Full Text] [Related]

  • 24. Fractionation of plasma membrane-associated tumor-specific antigen from an aminoazo dye-induced rat hepatoma.
    Baldwin RW, Harris JR, Price MR.
    Int J Cancer; 1973 Mar 15; 11(2):385-97. PubMed ID: 4364263
    [No Abstract] [Full Text] [Related]

  • 25. The isolation of normal rat liver h proteins and the immunological reactions of mouse anti-rat liver h protein.
    Louis CJ, Blunck JM.
    Cancer Res; 1970 Jul 15; 30(7):2043-8. PubMed ID: 4318465
    [No Abstract] [Full Text] [Related]

  • 26. Solubilization of tumour-specific antigen from plasma membrane of an aminoazo-dye-induced rat hepatoma.
    Baldwin RW, Glaves D.
    Clin Exp Immunol; 1972 May 15; 11(1):51-6. PubMed ID: 4338951
    [Abstract] [Full Text] [Related]

  • 27. Detection of hepatoma associated embryonic antigen in tumour-bearer serum.
    Rees RC, Price MR, Shan LP, Baldwin RW.
    Transplantation; 1975 May 15; 19(5):424-9. PubMed ID: 168675
    [Abstract] [Full Text] [Related]

  • 28. Tumour-specific complement-dependent serum cytotoxicity against a chemically induced rat hepatoma.
    Price MR, Baldwin RW.
    Int J Cancer; 1977 Aug 15; 20(2):284-91. PubMed ID: 197028
    [Abstract] [Full Text] [Related]

  • 29. A distinctive antigen present in liver carcinomas induced by 3'-methyl-p-dimethylaminoazobenzene.
    Carruthers C, Baumler A, Neilson A.
    Oncology; 1977 Aug 15; 34(2):47-51. PubMed ID: 70767
    [Abstract] [Full Text] [Related]

  • 30. Isolation of membrane-associated tumour-specific antigen from an aminoazo-dye-induced rat hepatoma.
    Baldwin RW, Moore M.
    Int J Cancer; 1969 Nov 15; 4(6):753-60. PubMed ID: 4314170
    [No Abstract] [Full Text] [Related]

  • 31. [Membrane antigens of Zajdela ascitic hepatoma].
    Ivanov VA, Fel' VIa, Olenov IuM.
    Tsitologiia; 1975 Jan 15; 17(1):24-9. PubMed ID: 164069
    [Abstract] [Full Text] [Related]

  • 32. Studies on the microcytotoxicity test. I. Evidence that the effects of normal lymphoid cells on tumour cell growth in microtest plates may be caused by non-immunological modifications of the culture medium.
    Brooks CG, Rees RC, Baldwin RW.
    Int J Cancer; 1976 Dec 15; 18(6):778-86. PubMed ID: 186418
    [Abstract] [Full Text] [Related]

  • 33. [Anomalous antigens in experimental hepatocarcinogenesis].
    Khundanova LL.
    Vopr Onkol; 1971 Dec 15; 17(3):85-90. PubMed ID: 4327424
    [No Abstract] [Full Text] [Related]

  • 34. Tumour-specific antibody neutralization of factors in rat hepatoma-bearer serum which abrogate lymph-node-cell cytotoxicity.
    Robins RA, Baldwin RW.
    Int J Cancer; 1974 Nov 15; 14(5):589-97. PubMed ID: 4376528
    [No Abstract] [Full Text] [Related]

  • 35. Solubilization of membrane-associated tumour-specific antigens by beta-glucosidase.
    Baldwin RW, Bowen JG, Price MR.
    Biochim Biophys Acta; 1974 Oct 10; 367(1):47-58. PubMed ID: 4370726
    [No Abstract] [Full Text] [Related]

  • 36. Studies on rat complement. II. Complement level in experimental tumor in rats.
    Sakamoto M, Nishioka K.
    Jpn J Exp Med; 1975 Jun 10; 45(3):191-8. PubMed ID: 170442
    [Abstract] [Full Text] [Related]

  • 37. Tumour-associated antigens and tumour-host interactions.
    Baldwin RW.
    Proc R Soc Med; 1971 Oct 10; 64(10):1039-42. PubMed ID: 4335921
    [No Abstract] [Full Text] [Related]

  • 38. Tumour rejection antigens associated with carcinogen-induced tumours.
    Baldwin RW, Price MR.
    Ric Clin Lab; 1977 Oct 10; 7(2):102-11. PubMed ID: 72398
    [Abstract] [Full Text] [Related]

  • 39. Tumour rejection in rats sensitized to embryonic tissue. I. Rejection of tumour cells implanted s.c. and detection of cytotoxic lymphoid cells.
    Shah LP, Rees RC, Baldwin RW.
    Br J Cancer; 1976 Jun 10; 33(6):577-83. PubMed ID: 181040
    [Abstract] [Full Text] [Related]

  • 40. Antigens common to rat hepatomas induced with 2-acetylaminofluorene.
    Isojima S, Yagi Y, Pressman D.
    Cancer Res; 1969 Jan 10; 29(1):140-4. PubMed ID: 4179169
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.